• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Orion Corporation - Articles and news items


Bayer and Orion expand BAY-1841788 programme in prostate cancer

Industry news / 3 June 2016 / Victoria White, Digital Content Producer

The Phase III study ARASENS will evaluate BAY-1841788 in men with newly diagnosed metastatic hormone-sensitive prostate cancer…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +